Terms: = Pancreatic cancer AND CD52, CDW52, EDDM5
3 results:
1. Neoadjuvant chemotherapy-induced remodeling of human hormonal receptor-positive breast cancer revealed by single-cell RNA sequencing.
Jia F; Sun S; Li J; Wang W; Huang H; Hu X; Pan S; Chen W; Shen L; Yao Y; Zheng S; Chen H; Xia W; Yuan H; Zhou J; Yu X; Zhang T; Zhang B; Huang J; Ni C
Cancer Lett; 2024 Mar; 585():216656. PubMed ID: 38266804
[TBL] [Abstract] [Full Text] [Related]
2. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-cd52 monoclonal antibodies.
Masuyama J; Murakami T; Iwamoto S; Fujita S
Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
[TBL] [Abstract] [Full Text] [Related]
3. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
[TBL] [Abstract] [Full Text] [Related]
